Literature DB >> 9449493

The therapeutic use of hematopoietic growth factors.

J J Costa1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9449493     DOI: 10.1016/S0091-6749(98)70185-X

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

Review 1.  Colony-stimulating factors for the management of neutropenia in cancer patients.

Authors:  David C Dale
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Filgrastim in patients with neutropenia: potential effects on quality of life.

Authors:  Gary H Lyman; Nicole M Kuderer
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation.

Authors:  Eri Takematsu; Miles Massidda; Jeff Auster; Po-Chih Chen; ByungGee Im; Sanjana Srinath; Sophia Canga; Aditya Singh; Marjan Majid; Michael Sherman; Andrew Dunn; Annette Graham; Patricia Martin; Aaron B Baker
Journal:  Nat Commun       Date:  2022-05-06       Impact factor: 17.694

Review 4.  Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges.

Authors:  Muluneh Ademe
Journal:  Front Cell Infect Microbiol       Date:  2020-09-15       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.